203 related articles for article (PubMed ID: 30043286)
21. Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance.
Kopleman SH; NguyenPho A; Zito WS; Muller FX; Augsburger LL
AAPS PharmSci; 2001; 3(4):E26. PubMed ID: 12049489
[TBL] [Abstract][Full Text] [Related]
22. A review of issues of nomenclature and taxonomy of Hypericum perforatum L. and Kew's Medicinal Plant Names Services.
Dauncey EA; Irving JTW; Allkin R
J Pharm Pharmacol; 2019 Jan; 71(1):4-14. PubMed ID: 29034955
[TBL] [Abstract][Full Text] [Related]
23. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
[TBL] [Abstract][Full Text] [Related]
24. Study of dynamic accumulation of secondary metabolites in three subspecies of Hypericum perforatum.
Filippini R; Piovan A; Borsarini A; Caniato R
Fitoterapia; 2010 Mar; 81(2):115-9. PubMed ID: 19686808
[TBL] [Abstract][Full Text] [Related]
25. Herbal drug quality and phytochemical composition of Hypericum perforatum L. affected by ash yellows phytoplasma infection.
Bruni R; Pellati F; Bellardi MG; Benvenuti S; Paltrinieri S; Bertaccini A; Bianchi A
J Agric Food Chem; 2005 Feb; 53(4):964-8. PubMed ID: 15713006
[TBL] [Abstract][Full Text] [Related]
26. Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids.
Denke A; Schempp H; Weiser D; Elstner EF
Arzneimittelforschung; 2000 May; 50(5):415-9. PubMed ID: 10858868
[TBL] [Abstract][Full Text] [Related]
27. Effect of St.John's wort (Hypericum perforatum) oily extract for the care and treatment of pressure sores; a case report.
Yücel A; Kan Y; Yesilada E; Akın O
J Ethnopharmacol; 2017 Jan; 196():236-241. PubMed ID: 28011162
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive phytochemical characterization of St. John's wort (
Heinrich M; Daniels R; Stintzing FC; Kammerer DR
Pharmazie; 2017 Mar; 72(3):131-138. PubMed ID: 29442047
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of the active components and the by-products of eight dry extracts of Hypericum perforatum L. (St John's Wort).
von Eggelkraut-Gottanka SG; Abu Abed S; Müller W; Schmidt PC
Phytochem Anal; 2002; 13(3):170-6. PubMed ID: 12099108
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice.
Xiong A; Shao Y; Fang L; Yang X; Zhang S; Zheng J; Ding W; Yang L; Wang Z
Phytomedicine; 2019 Feb; 54():77-88. PubMed ID: 30668385
[TBL] [Abstract][Full Text] [Related]
31. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
Galeotti N
J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
[TBL] [Abstract][Full Text] [Related]
32. [Hypericum perforatum L., St. John's wort, a medicinal plant in folk medicine].
Kopp B
Wien Med Wochenschr; 1999; 149(8-10):190. PubMed ID: 10483678
[No Abstract] [Full Text] [Related]
33. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
[TBL] [Abstract][Full Text] [Related]
34. Elemental, nutritional, phytochemical and biological evaluation of Hypericum perforatum Linn.
Dastagir G; Ahmed R; Shereen S
Pak J Pharm Sci; 2016 Mar; 29(2):547-55. PubMed ID: 27087099
[TBL] [Abstract][Full Text] [Related]
35. Hyperforin production in Hypericum perforatum root cultures.
Gaid M; Haas P; Beuerle T; Scholl S; Beerhues L
J Biotechnol; 2016 Mar; 222():47-55. PubMed ID: 26876610
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interactions of drugs with St John's wort.
Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
[TBL] [Abstract][Full Text] [Related]
37. Metabolome classification of commercial Hypericum perforatum (St. John's Wort) preparations via UPLC-qTOF-MS and chemometrics.
Farag MA; Wessjohann LA
Planta Med; 2012 Mar; 78(5):488-96. PubMed ID: 22271082
[TBL] [Abstract][Full Text] [Related]
38. Pseudohypericin and hyperforin in Hypericum perforatum from Northern Turkey: variation among populations, plant parts and phenological stages.
Cirak C; Radusiene J; Janulis V; Ivanauskas L
J Integr Plant Biol; 2008 May; 50(5):575-80. PubMed ID: 18713425
[TBL] [Abstract][Full Text] [Related]
39. Quality control of Hypericum perforatum L. analytical challenges and recent progress.
Agapouda A; Booker A; Kiss T; Hohmann J; Heinrich M; Csupor D
J Pharm Pharmacol; 2019 Jan; 71(1):15-37. PubMed ID: 28266019
[TBL] [Abstract][Full Text] [Related]
40. Antinociceptive Properties of St. John's Wort (Hypericum perforatum) and Other Hypericum Species.
Stojanović NM; Radulović NS; Randjelović PJ; Laketić D
Nat Prod Commun; 2016 Nov; 11(11):1741-1747. PubMed ID: 30475520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
